Tardive dyskinesia (TD) is a syndrome of abnormal involuntary movements that follows
treatment with dopamine D2-receptor antagonists. Recent approval of vesicular monoamine …

Tardive dyskinesia (TD) is a heterogeneous, hyperkinetic movement disorder induced by
dopamine-receptor blocking agents that presents a unique challenge in the treatment of …

Catatonia occurs secondary to both primary psychiatric and neuromedical etiologies.
Emerging evidence suggests possible linkages between causes of catatonia and …

Hydrazides, NN containing structural motifs, are important due to their presence in a wide
variety of biologically significant compounds. While the homo NN coupling of two NH …

Drug-induced movement disorders (DIMDs) are a group of neurological conditions caused
by the use of certain medications. These disorders can significantly impact a person's quality …

Drug-induced movement disorders (DIMDs) are associated with use of dopamine receptor
blocking agents (DRBAs), including antipsychotics. The most common forms are drug …

Introduction Antipsychotics are the foundation of pharmacologic treatment for schizophrenia.
There are many oral antipsychotics available and given that these medications are generally …

Cariprazine is one of the newer generation antipsychotics with dopamine receptor partial
agonist activity which has been approved for management of schizophrenia and bipolar …

Лекарственные дискинезии-состояние, достаточно часто развивающееся на фоне
приема лекарственных средств, преимущественно нейролептиков. Экстрапирамидные …

Since the original description of neuroleptic malignant syndrome (NMS) over 60 years ago,
a wealth of clinical data has accumulated on the clinical features, treatment, and …